- ►annals.org SD Aaron, KL Vandemheen, D Fergusson, F … - Annals of internal medicine, 2007 - Am Coll Physicians Background: Treatment of moderate or severe chronic obstructive pulmonary
disease (COPD) with combinations of inhaled corticosteroids, long-acting
ß-agonists, and long-acting anticholinergic bronchodilators is common but ... Cited by 140 - Related articles - BL Direct - All 6 versions
- ►ecu.edu [PDF] P Calverley, JA Anderson, B Celli, GT … - The New England journal of medicine, 2007 - nejm.highwire.org From University Hospital Aintree, Liver- pool, United Kingdom (PMAC); Glaxo-
SmithKline Research and Development, Greenford, United Kingdom (JAA); Cari- tas
St. Elizabeth's Medical Center, Boston (BC); Pulmonary Research Institute ... Cited by 593 - Related articles - BL Direct - All 24 versions
- ►ersjournals.com JA Van Noord, JL Aumann, E Janssens, JJ … - European Respiratory Journal, 2005 - Eur Respiratory Soc Compared with baseline (FEV 1 prior to the first dose in the first period),
tiotropium produced a significantly greater improvement in average daytime FEV 1
(0–12 h) than formoterol (127 versus 86 mL), while average night-time FEV ... Cited by 156 - Related articles - BL Direct - All 9 versions
- ►chestpubs.org JA van Noord, JL Aumann, E Janssens, J … - Chest, 2006 - chestjournal.chestpubs.org Results: Mean baseline FEV 1 was 1.05 L (38% of predicted). There was a
circadian variation in FEV 1 , FVC, and IC at baseline that was maintained
during all treatment periods. Average FEV 1 (0 to 24 h) improved by 0.08 L ... Cited by 128 - Related articles - BL Direct - All 7 versions
- ►atsjournals.org S Suissa - American journal of respiratory and critical care …, 2006 - Am Thoracic Soc Randomized trials and a meta-analysis suggesting that inhaled corticosteroids
reduce exacerbation rates in patients with chronic obstructive pulmonary disease
(COPD) show major discrepancies that may be due to different approaches to ... Cited by 59 - Related articles - BL Direct - All 9 versions
- ►atsjournals.org JA Wedzicha, P Calverley, TA Seemungal, G … - American journal of respiratory and critical care …, 2008 - Am Thoracic Soc Measurements and Main Results: Primary endpoint was health care utilization
exacerbation rate. Other endpoints included health status measured by St.
George's Respiratory Questionnaire (SGRQ), mortality, adverse events, and ... Cited by 81 - Related articles - BL Direct - All 12 versions
- ►nih.gov RG Barr, J Bourbeau, CA Camargo Jr, FSF … - British Medical Journal, 2006 - thorax.bmj.com Online First articles must include the digital object identifier (DOIs) and date
of initial publication. establish publication priority; they are indexed by
PubMed from initial publication. Citations to may be posted when available ... Cited by 104 - Related articles - BL Direct - All 9 versions
P Kardos, M Wencker, T Glaab, C Vogelmeier - American journal of respiratory and critical care …, 2007 - Am Thoracic Soc Main Results: The total number of exacerbations was 334 in the combination
therapy and 464 in the salmeterol group (p < 0.0001). The annualized rate of
moderate and severe exacerbations per patient was 0.92 in the combination ... Cited by 95 - Related articles - BL Direct - All 8 versions
- ►atsjournals.org P Ernst, AV Gonzalez, P Brassard, S Suissa - American journal of respiratory and critical care …, 2007 - Am Thoracic Soc Measurements and Main Results: The cohort included 175,906 patients with COPD of
whom 23,942 were hospitalized for pneumonia during follow-up, for a rate of 1.9
per 100 per year, and matched to 95,768 control subjects. The adjusted rate ... Cited by 72 - Related articles - BL Direct - All 6 versions
- ►chestpubs.org JB Soriano, DD Sin, X Zhang, PG Camp, JA … - Chest, 2007 - chestjournal.chestpubs.org * From the Program of Epidemiology and Clinical Research (Dr. Soriano),
Fundació Caubet-CIMERA Illes Balears, International Centre for Advanced
Respiratory Medicine, Bunyola, Mallorca, Illes Balears, Spain; James Hogg ... Cited by 65 - Related articles - BL Direct - All 9 versions
